All Stories

  1. The Use Of Molecular Docking And Spectroscopic Methods For Investigation Of The Interaction Between Regorafenib With Human Serum Albumin (HSA) And Calf Thymus DNA (Ct-DNA) In The Presence Of Different Site Markers
  2. Assessment of CEP55, PLK1 and FOXM1 expression in patients with bladder cancer in comparison with healthy individuals
  3. Association between rs2278426 (C/T) and rs892066 (C/G) variants of ANGPTL8 (betatrophin) and susceptibility to type2 diabetes mellitus
  4. Anticancer activity, Calf thymus DNA and Human serum albumin binding properties of Farnesiferol C from Ferula pseudalliacea
  5. In vitro cytotoxicity and DNA/HSA interaction study of triamterene using molecular modelling and multi-spectroscopic methods
  6. Amelioration of diabetes-induced testicular and sperm damage in rats by cerium oxide nanoparticle treatment
  7. Zerumbone inhibits epithelial-mesenchymal transition and cancer stem cells properties by inhibiting the β-catenin pathway through miR-200c
  8. The Potential Use of Peptides in Cancer Treatment
  9. Pumping of drug molecules out of bacterial cells is a major mechanism of antibiotic resistance
  10. miR-200c, a tumor suppressor that modulate the expression of cancer stem cells markers and epithelial-mesenchymal transition in colorectal cancer
  11. Human serum albumin binding and synergistic effects of gefitinib in combination with regorafenib on colorectal cancer cell lines
  12. Binding site identification of anticancer drug gefitinib to HSA and DNA in the presence of five different probes
  13. Efflux proteins at the blood–brain barrier: review and bioinformatics analysis
  14. MicroRNA-124 Regulates Neuronal Differentiation of Mesenchymal Stem Cells by Targeting Sp1 mRNA